Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 05 1997, 1244-1247, Vol 35, No. 5
DL Thomas, PO Yarbough, D Vlahov, SA Tsarev, KE Nelson, AJ Saah and RH Purcell
If the occurrence of hepatitis E virus antibody (anti-HEV) in regions where
the disease is not endemic represents infection, rates may be greater in
high-risk populations and behavioral correlates may reflect recognized
transmission modes. Serum samples from 300 homosexual males, 300 injection
drug users (IDUs), and 300 blood donors from Baltimore, Md., were tested
for anti-HEV by enzyme immunoassay. Anti-HEV was found in an unexpectedly
high percentage of homosexual men (15.9%) and IDUs (23.0%). However,
anti-HEV was present in a similar proportion of blood donors (21.3%) (P
> 0.05), while hepatitis A, B, and C virus antibodies were more
prevalent in the high-risk groups (P < 0.001). Among homosexual men,
anti-HEV was not significantly correlated with a history of hepatitis,
high-risk sexual practices, or sexually transmitted infections, in contrast
to hepatitis A and B antibodies. Among IDUs, anti-HEV was not significantly
associated with a history of hepatitis or high-risk drug-using practices,
as was found with hepatitis C antibodies. In a setting without endemic
hepatitis E disease, there was no evidence that anti-HEV reflected
subclinical infection. Until the basis for HEV seroreactivity in such areas
is elucidated, anti-HEV results should be interpreted with caution.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Seroreactivity to hepatitis E virus in areas where the disease is not endemic
Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. dthomas@welchlink.welch.jhu.edu
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|